Developing phage display tools for use in transfusion medicine
2005; Wiley; Volume: 45; Issue: s2 Linguagem: Inglês
10.1111/j.1537-2995.2005.00534.x
ISSN1537-2995
Autores Tópico(s)Glycosylation and Glycoproteins Research
ResumoTransfusionVolume 45, Issue s2 p. 100S-108S Developing phage display tools for use in transfusion medicine Don L. Siegel, Corresponding Author Don L. Siegel From the Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.Don L. Siegel, PhD, MD, Division of Transfusion Medicine, Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; e-mail: [email protected].Search for more papers by this author Don L. Siegel, Corresponding Author Don L. Siegel From the Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.Don L. Siegel, PhD, MD, Division of Transfusion Medicine, Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; e-mail: [email protected].Search for more papers by this author First published: 29 July 2005 https://doi.org/10.1111/j.1537-2995.2005.00534.xCitations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Siegel DL, Goodman SR, Branton D. The effect of endogenous proteases on the spectrin binding proteins of human erythrocytes. Biochim Biophys Acta 1980; 598: 517-27. 2 Siegel D, Branton D. Partial purification and characterization of an actin bundling protein, band 4.9, from human erythrocytes. J Cell Biol 1985; 100: 775-85. 3 Branton D, Siegel DL. Electron microscopy of red cell cytoskeletal proteins. In: SB Shohet, N Mohandas, editors. Methods in hematology. New York: Churchill-Livingston; 1988. p. 1-16. 4 Siegel DL. Research and clinical applications of antibody phage display in transfusion medicine. Transfus Med Rev 2001; 15: 35-52. 5 Siegel DL. Recombinant monoclonal antibody technology. Transfus Clin Biol 2002; 9: 15-22. 6 Siegel DL. Diagnostic and therapeutic applications of phage display technology. In: CP Stowell, WH Dzik, editors. Emerging technologies and therapies in transfusion medicine. Bethesda: American Association of Blood Banks; 2003. p. 55-93. 7 Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228: 1315-7. 8 Siegel DL, Silberstein LE. Expression and characterization of recombinant anti-Rh(D) antibodies on filamentous phage: a model system for isolating human red blood cell antibodies by repertoire cloning. Blood 1994; 83: 2334-44. 9 Siegel DL, Chang TY, Russell SL, Bunya VY. Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting. Applications Immunohematol J Immunol Methods 1997; 206: 73-85. 10 Siegel DL. Isolation of human anti-red blood cell antibodies by repertoire cloning. Ann N Y Acad Sci 1995; 764: 547-58. 11 Thompson KM, Hough DW, Maddison PJ, et al. The efficient production of stable human monoclonal antibody secreting hybridomas from EBV transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. J Immunol Methods 1986; 94: 7-12. 12 Thompson KM, Melamed MD, Eagle K, et al. Production of human monoclonal IgG and IgM antibodies with anti-D (Rh) specificity using heterohybridomas. Immunology 1986; 58: 157-60. 13 Melamed MD, Thompson KM, Gibson T, Hughes-Jones NC. Requirements for the establishment of heterohybridomas secreting monoclonal human antibody to rhesus (D) blood group antigen. J Immunol Methods 1987; 104: 245-51. 14 Goossens D, Champomier F, Rouger P, Salmon C. Human monoclonal antibodies against blood group antigens. J Immunol Methods 1987; 101: 193-200. 15 Kumpel BM, Poole GD, Bradley BA. Human monoclonal anti-D antibodies. I. Their production, serology, quantitation, and potential use as blood grouping reagents. Br J Hematol 1989; 71: 125-9. 16 Rapaille A, Francois-Gerard C, Donnay D, Sondag-Thull D. Production of stable human-mouse hybridomas secreting monoclonal antibodies against Rh D and c antigens. Vox Sang 1993; 64: 161-6. 17 Thompson JM, Lowe J, McDonald DF. Human monoclonal anti-D secreting heterohybridomas from peripheral B lymphocytes expanded in the CD40 system. J Immunol Methods 1994; 175: 137-40. 18 Boucher G, Broly H, Lemieux R. Restricted use of cationic germline VH gene segments in human Rh(D) red cell antibodies. Blood 1997; 89: 3277-86. 19 Siegel DL. Cell-surface panning of phage-display libraries. In: CF Barbas, DR Burton, GJ Silverman, JK Scott, editors. Phage display of proteins and peptides: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2001. p. 23.1-.32. 20 Siegel DL. Selecting immunoglobulins to cell-surface antigens using magnetic sorting techniques. In: R Aitkem, PM O'Brien, editors. Methods in molecular biology: antibody phage display: methods and protocols. Totowa NJ: Humana Press; 2002. p. 219-26. 21 Chang TY, Siegel DL. Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: implications for Rh(D) epitope topology. Blood 1998; 91: 3066-78. 22 Siegel DL. The human immune response to red blood cell antigens as revealed by repertoire cloning. Immunol Res 1998; 17: 239-51. 23 Siegel DL, Chang TY. Epitope migration: anti-Rh(D) antibodies as a model for human immunogenicity. Blood 1998; 92: 671a. 24 Chang TY, Siegel DL. Epitope migration of anti-D antibodies. Transfusion 1998; 38: 61S. 25 Chang TY, Siegel DL. Isolation of an IgG anti-B from a human Fab-phage display library. Transfusion 2001; 41: 6-12. 26 Siegel DL. Understanding immunogenicity on a molecular level. New insights revealed by the Rh immune response. Blood 2001; 99: 100a. 27 Mollison PL, Engelfreit CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Scientific; 1997. 28 Siegel DL. Phage display tools for automated blood typing. Transfusion 2004; 44: 2a. 29 Cines DB, McKenzie SE, Siegel DL. Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003; 25: S52-6. 30 Roark JH, Bussel JB, Cines DB, Siegel DL. Genetic analysis of autoantibodies in ITP reveals evidence of clonal expansion and somatic mutation. Blood 2002; 100: 1388-98. 31 Silverman GJ, Goodyear CS, Siegel DL. On the mechanism of Staphylococcal protein A immunomodulation. Transfusion 2005; 45: 274-80. 32 Siegel DL, Loftus JC, McMillan R. Characterization of an ITP patient-derived anti-α2bβ3 monoclonal antibody that inhibits platelet aggregation. Blood 2003; 102: 87a. 33 Payne AS, Ishii K, Kacir S, et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005; 115: 888-99. 34 Lomas C, McColl K, Tippett P. Further complexities of the Rh antigen D disclosed by testing category DII cells with monoclonal anti-D. Transfus Med 1993; 3: 67-9. Citing Literature Volume45, Issues2August 2005Pages 100S-108S ReferencesRelatedInformation
Referência(s)